A

Adaptive Biotechnologies Corp

D
ADPT
USD
-0.275
(-4.6968%)
Market Closed
43,828.00
حجم التداول
-1.287
الربح لكل سهم
-
العائد الربحي
-3.795918
P/E
822,894,881.58
حجم السوق
اليوم
-4.6968%
1 اسبوع
-0.888%
1 شهر
12.727%
6 اشهر
41.266%
12 اشهر
36.430%
بداية السنة
13.761%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Adaptive Biotechnologies Corp

Sector:
Healthcare
Industry:
Biotechnology
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product,clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is alsoavailable as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
هل تحتاج مساعدة او لديك استفسار؟